0001214659-23-010670.txt : 20230802 0001214659-23-010670.hdr.sgml : 20230802 20230802170013 ACCESSION NUMBER: 0001214659-23-010670 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230724 FILED AS OF DATE: 20230802 DATE AS OF CHANGE: 20230802 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Agafonova Nataliya CENTRAL INDEX KEY: 0001985443 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40060 FILM NUMBER: 231136707 MAIL ADDRESS: STREET 1: 1951 NW 7TH AVENUE CITY: MIAMI STATE: FL ZIP: 33136 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Longeveron Inc. CENTRAL INDEX KEY: 0001721484 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 472174146 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1951 NW 7TH AVENUE STREET 2: SUITE 520 CITY: MIAMI STATE: FL ZIP: 33136 BUSINESS PHONE: 305-302-7158 MAIL ADDRESS: STREET 1: 1951 NW 7TH AVENUE STREET 2: SUITE 520 CITY: MIAMI STATE: FL ZIP: 33136 FORMER COMPANY: FORMER CONFORMED NAME: LONGEVERON LLC DATE OF NAME CHANGE: 20171101 4 1 marketforms-62164.xml PRIMARY DOCUMENT X0508 4 2023-07-24 0001721484 Longeveron Inc. LGVN 0001985443 Agafonova Nataliya 1951 NW 7TH AVENUE, SUITE 520 MIAMI FL 33136 false true false false Chief Medical Officer 0 Common Stock 2023-07-24 4 A false 30000 0 A 30000 D Represents the award of 30,000 Restricted Stock Units, which vest 25% on each of the award date, October 1, 2023, January 1, 2024, and April 1, 2024. Includes 22,500 Restricted Stock Units. /s/ Paul Lehr, attorney-in-fact 2023-08-01